Akebia Therapeutics Inc share price logo

Akebia Therapeutics Inc Share Price

NASDAQ: AKBA

Small Cap

$3.03

-0.09

(-2.88%)

Live

as on

Akebia Therapeutics Inc Stock Performance

as on September 4, 2025 at 11:38 pm IST

  • Day's High

    $3.03
    $3.14

    3.63%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.24
    $4.08
    downward going graph

    59.08%

    Downside

    34.61%

    Upside

    downward going graph

Akebia Therapeutics Inc share price movements today

Previous Close
$3.12
Open
$3.10
Volume
1.8M
Day's Low - High
$3.03 - $3.14
52 Week Low - High
$1.24 - $4.08

Akebia Therapeutics Inc Historical Returns

1 Month Return
-17.02 %
3 Month Return
-14.29 %
1 Year Return
+ 123.66 %
3 Year Return
+ 721.05 %
5 Year Return
+ 14.71 %

Akebia Therapeutics Inc Stock Fundamentals & Key Indicators

Check Akebia Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$827.3M

EPS (TTM)

-0.03

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7.78

Industry PE ratio

-4.14

P/B Ratio

0

PEG Ratio

0

EBITDA

23.3M

Revenue (TTM)

203.7M

Profit Margin

-17.91%

Return On Equity TTM

4606300.00%

Akebia Therapeutics Inc Stock Valuation

Track how Akebia Therapeutics Inc P/E has moved over time to understand its valuation trends.

Akebia Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 4, 2025

Today (-7.78x)

September 4, 2025

Industry (-4.14x)

September 4, 2025

Highest (-0.49x)

September 30, 2022

LowHigh

Today’s Price to Earnings Ratio: -7.78x

Akebia Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Akebia Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$827.3M14.71%-7.78-17.91%
BUY$44.3BNA21.9813.81%
BUY$17.7BNA15.2840.36%
BUY$13.5B23.67%40.2713.88%
BUY$67.6BNA26.2427.83%

Stock Returns calculator for Akebia Therapeutics Inc Stock including INR - Dollar returns

The Akebia Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Akebia Therapeutics Inc investment value today

Current value as on today

₹2,21,443

Returns

₹1,21,443

(+121.44%)

Returns from Akebia Therapeutics Inc Stock

₹1,16,429 (+116.43%)

Dollar Returns*

₹5,014 (+5.01%)

Analyst Recommendation on Akebia Therapeutics Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Akebia Therapeutics Inc. Average target price of $7.4

Akebia Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Akebia Therapeutics Inc.

What analysts predicted

59.05%UPSIDE

Target Price

$7.4

Current Price

$3.03

Analyzed by

9 Analysts

Target

$7.40

Akebia Therapeutics Inc target price $7.4, a slight upside of 59.05% compared to current price of $3.03. According to 9 analysts rating.

Akebia Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Akebia Therapeutics Inc Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-52% versus previous 30 day period

Akebia Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
40
56
42
56
32
43
37
46
57
62
Gross Profit
20
39
24
37
20
26
23
26
49
52
Operating Income
-24
-8
-13
1
-14
-8
-12
-14
13
14
EBITDA
-15
0
-3
12
-6
2
-4
-6
14
7
Interest Expense
1
1
1
1
2
2
6
6
7
6
Depreciation
9
9
9
14
9
9
9
9
0
0
Income Before Tax
-26
-11
-14
0
-17
-8
-20
-22
6
0
Income Tax Expense
-9
0
1
0
9
-
-
-
-
-
Net Income
-16
-11
-14
0
-17
-8
-20
-22
6
0
Net Profit Margin
-41.71%
-19.82%
-34.46%
1.09%
-55.16%
-19.66%
-53.54%
-49.04%
10.66%
0.40%

Akebia Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
1
177
207
335
295
213
292
194
160
Gross Profit
0
-114
177
200
189
0
60
207
120
97
Operating Income
-61
-136
-79
-178
-286
-376
-265
-63
-46
-50
EBITDA
-61
-136
-76
-175
-247
-342
-227
-43
-6
-13
Interest Expense
0
0
2
6
38
8
19
15
6
18
Depreciation
-
-
0
2
38
33
37
37
37
37
Income Before Tax
-60
-135
-76
-171
-286
-383
-282
-92
-51
-69
Income Tax Expense
0
0
-2
-28
-6
-33
-37
13
41
-
Net Income
-60
-135
-76
-171
-279
-349
-244
-106
-51
-69
Net Profit Margin
0.00%
-8843.45%
-43.21%
-82.75%
-83.48%
-118.48%
-114.65%
-36.23%
-26.68%
-43.33%

Akebia Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-11
-14
0
-17
-8
-20
-22
6
0
Operating Cash Flow
3
-7
-2
-19
-10
-6
-4
-13
22
Investing Cash Flow
-
-
-
-
0
0
0
0
0
Financing Cash Flow
-8
0
-1
18
7
1
22
74
1
Change in Cash
-4
-7
-3
0
-2
-5
17
61
23

Akebia Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-135
-76
-143
-279
-383
-282
-92
-51
-69
Operating Cash Flow
57
-56
-97
-257
-110
-252
-73
-23
-40
Investing Cash Flow
12
-177
36
211
-40
39
0
-
0
Financing Cash Flow
66
116
96
88
231
133
14
-25
49
Change in Cash
137
-117
35
42
81
-79
-58
-48
8

Global Institutional Holdings in Akebia Therapeutics Inc

Funds
Holdings
BlackRock Inc
5.83%
Vanguard Group Inc
4.82%
State Street Corp
2.59%
Geode Capital Management, LLC
1.91%
Great Point Partners LLC
1.89%

Insights on Akebia Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AKBA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 37.42M → 62.47M (in $), with an average increase of 15.5% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AKBA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, AKBA stock has moved up by 717.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 6.11M → 247.0K (in $), with an average decrease of 96.0% per quarter

About Akebia Therapeutics Inc

akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients. akebia’s global phase 3 program for vadadustat, which includes the pro2tect studies for non-dialysis patients with anemia associated with chronic kidney disease and the inno2vate studies for dialysis-dependent patients, is currently ongoing. for more information, please visit our website at www.akebia.com.
OrganisationAkebia Therapeutics Inc
Headquarters245 First Street, Cambridge, MA, United States, 02142
IndustryHealth Technology
CEOMr. John P. Butler MBA
E-voting on sharesClick here to vote

Key Management of Akebia Therapeutics Inc

Name

Title

Mr. Nicholas Grund

Senior VP & Chief Commercial Officer

Ms. Carolyn Rucci

Senior VP of Legal, General Counsel & Secretary

Ms. Meredith Bowman

Senior VP & Chief People Officer

Mr. John P. Butler MBA

CEO, President & Director

Mr. Erik John Ostrowski M.B.A.

Chief Business Officer, Senior VP, CFO & Treasurer

Dr. Steven Keith Burke M.D.

Senior VP of Research & Development and Chief Medical Officer

Mr. Richard C. Malabre

Chief Accounting Officer

Ms. Kimberly Garko

Senior VP & Chief Technical Officer

Ms. Tracey Vetterick

Vice President of Portfolio Strategy & Corporate Administration

Mercedes Carrasco

Senior Director of Investor & Corporate Communications

FAQs

What is Akebia Therapeutics Inc share price today?

Akebia Therapeutics Inc share price today is $3.03 as on . Akebia Therapeutics Inc share today touched a day high of $3.14 and a low of $3.03.

What is the 52 week high and 52 week low for Akebia Therapeutics Inc share?

Akebia Therapeutics Inc share touched a 52 week high of $4.08 on and a 52 week low of $1.24 on . Akebia Therapeutics Inc stock price today i.e. is trending at $3.03,which is 25.71% down from its 52 week high and 144.35% up from its 52 week low.

What is Akebia Therapeutics Inc's market capitalisation today?

Akebia Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Akebia Therapeutics Inc Stock (AKBA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Akebia Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Akebia Therapeutics Inc Shares that will get you 0.4950 shares as per Akebia Therapeutics Inc share price of $3.03 per share as on September 4, 2025 at 11:38 pm IST.

What is the minimum amount required to buy Akebia Therapeutics Inc Stock (AKBA) from India?

Indian investors can start investing in Akebia Therapeutics Inc (AKBA) shares with as little as ₹88.115 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.15 in Akebia Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Akebia Therapeutics Inc share’s latest price of $3.03 as on September 4, 2025 at 11:38 pm IST, you will get 3.3003 shares of Akebia Therapeutics Inc. Learn more about fractional shares .

What are the returns that Akebia Therapeutics Inc has given to Indian investors in the last 5 years?

Akebia Therapeutics Inc stock has given 14.71% share price returns and 20.11% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?